Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3622188 | 0.96 | LMNA (0.41) | LMNAALDH1A1TSHRFGFR4MAPK1 | |
| SCHEMBL8743203 | 0.83 | LMNA (0.44) | LMNAALDH1A1TSHRFGFR4 | |
| SCHEMBL6379416 | 0.81 | ALDH1A1 (0.47) | LMNAALDH1A1TSHRFGFR4 | |
| SCHEMBL9567032 | 0.81 | ALDH1A1 (0.47) | LMNAALDH1A1TSHRFGFR4 | |
| SCHEMBL372525 | 0.81 | ALDH1A1 (0.47) | LMNAALDH1A1TSHRFGFR4 | |
| SCHEMBL2446840 | 0.81 | LMNA (0.30) | LMNA | |
| SCHEMBL8607630 | 0.76 | ALDH1A1 (0.43) | LMNAALDH1A1TSHRFGFR4 | |
| SCHEMBL4359317 | 0.74 | ALDH1A1 (0.46) | LMNAALDH1A1TSHRTDP1 | |
| SCHEMBL28441938 | 0.74 | ALDH1A1 (0.41) | LMNAALDH1A1TSHRTDP1 | |
| SCHEMBL7203144 | 0.74 | ALDH1A1 (0.41) | LMNAALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 970 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049219-A1 | REACTIVE GEL MATERIAL FOR SUSTAINED WATER-BASED REACTIONS | EVERBOND INTERFACE TECHNOLOGIES INC. (CA) | 2026-02-19 | — | — | US | claimed |
| EP-4636398-A2 | REACTIVE GEL MATERIAL FOR SUSTAINED WATER-BASED REACTIONS | Everbond Interface Technologies, Inc. (CA) | 2025-10-22 | — | — | EP | claimed |
| EP-4617656-A2 | REACTIVE GEL MATERIAL FOR SUSTAINED WATER-BASED REACTIONS | Everbond Interface Technologies, Inc. (CA) | 2025-09-17 | — | — | EP | claimed |
| EP-4532607-A1 | REACTIVE GEL MATERIAL FOR SUSTAINED WATER-BASED REACTIONS | Everbond Interface Technologies, Inc. (CA) | 2025-04-09 | — | — | EP | claimed |
| WO-2024129672-A1 | TRAFFICKED RNAS FOR ASSESSMENT OF CELL-CELL CONNECTIVITY AND NEUROANATOMY | THE BROAD INSTITUTE, INC. (US) | 2024-06-20 | — | — | WO | claimed |
| US-20240043915-A1 | METHODS AND COMPOSITIONS FOR IN SITU MACROMOLECULE DETECTION AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2024-02-08 | — | — | US | claimed |
| US-20240016706-A1 | MATERIALS FOR OBTURATION | SONENDO, INC. | 2024-01-18 | — | — | US | claimed |
| CN-113164882-B | Membrane for selective substance delivery | 科德宝两合公司 | 2023-12-22 | — | — | CN | claimed |
| WO-2023230720-A1 | REACTIVE GEL MATERIAL FOR SUSTAINED WATER-BASED REACTIONS | EVERBOND INTERFACE TECHNOLOGIES, INC. (CA) | 2023-12-07 | — | — | WO | claimed |
| WO-2023110783-A1 | POLYMER FOR DETECTING ALDEHYDES AND KETONES | AGROSUP (FR) | 2023-06-22 | — | — | WO | claimed |
| WO-2010062678-A2 | MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME | LIU DAVID (US) | 2010-06-03 | — | — | WO | claimed |
| WO-2010046084-A1 | MACROPOROUS POLYMERIC CROSSLINKED MATERIALS, METHOD FOR MANUFACTURE THEREOF AND USE | STICHTING DUTCH POLYMER INSTITUTE (NL) | 2010-04-29 | — | — | WO | claimed |
| EP-2179751-A1 | Macroporous polymeric crosslinked materials, method for manufacture thereof and use | Stichting Dutch Polymer Institute (NL) | 2010-04-28 | — | — | EP | claimed |
| US-6627720-B2 | Monoethylenically unsaturated monomers are polymerized with at least one multiethylenically unsaturated monomer at high temperatures by free radical polymerization in a continuous reactor, without formation of highly crosslinked gels | JOHNSON POLYMER, LLC | 2003-09-30 | — | — | US | claimed |
| US-6265511-B1 | BLEND OF DIVINYL MONOMER AND MONOETHYLENICALLY UNSATURATED MONOMER | S. C. JOHNSON COMMERICAL MARKETS, INC. | 2001-07-24 | — | — | US | claimed |
| EP-0241132-B1 | COMPOSITIONS SUITABLE IN OR AS FILM, COATING, MASTIC, ADHESIVE, CAULK COMPOSITIONS, AND A METHOD OF MAKING THEM | ROHM AND HAAS COMPANY (US) | 1991-07-03 | — | — | EP | claimed |
| EP-0405464-A2 | Polyether acrylamide derivatives and active energy ray curable resin composition | AJINOMOTO CO., INC. (JP) | 1991-01-02 | — | — | EP | claimed |
| US-4863990-A | Modified solution polymers for coatings, films, mastics, caulks, and adhesives | ROHM AND HAAS COMPANY (US) | 1989-09-05 | — | — | US | claimed |
| EP-0241132-A2 | Compositions suitable in or as film, coating, mastic, adhesive, caulk compositions, and a method of making them | ROHM AND HAAS COMPANY (US) | 1987-10-14 | — | — | EP | claimed |
| US-4043819-A | Photo-polymerizable material for the preparation of stable polymeric images and process for making them by photopolymerization in a matrix | CIBA-GEIGY AG (CH) | 1977-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049219-A1 | REACTIVE GEL MATERIAL FOR SUSTAINED WATER-BASED REACTIONS | DSG1, CTSG, PARG | LMNA 1232/4885ALDH1A1 3781/4885TSHR 2222/4885 |
| US-20240016706-A1 | MATERIALS FOR OBTURATION | ACR, GMPS, AAAS | LMNA 3013/4885ALDH1A1 225/4885TSHR 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.